Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in rats

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

G. Dark, S A Hill, Vivien E. Prise et al. · PubMed · 1997 · 624 citations

Medicine, Oncology, Pharmacology +13

Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging

Susan Galbraith, Ross J. Maxwell, Martin A. Lodge et al. · Journal of Clinical Oncology · 2003 · 326 citations

Medicine, Oncology, Pharmacology +16

Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.

G. M. Tozer, Vivien E. Prise, John Wilson et al. · PubMed · 1999 · 324 citations

Medicine, Oncology, Pharmacology +17

Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies

Oleg Tarnavski, Julie R. McMullen, Martina Schinke et al. · Physiological Genomics · 2004 · 318 citations

Life Sciences, Cardiology, Molecular Biology +12

Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results

Gordon Rustin, Susan Galbraith, Helén Anderson et al. · Journal of Clinical Oncology · 2003 · 307 citations

Pharmacy, Pharmacology, Pharmacotherapy +13